reference/3983097

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/3983097

Outgoing Links

Predicate	Object
contentType	Journal Article\|Review
endingPage	639
issn	1776-260X 1776-2596
issueIdentifier	5
pageRange	631-639
publicationName	Targeted Oncology
startingPage	631
bibliographicCitation	Zhang B, Zhang Y, Xu J, Zhang X, Chu T, Wang S, Qian J, Qiao R, Lu J, Zhang L, Han B. Characteristics and Response to Crizotinib in ALK-Rearranged, Advanced Non-Adenocarcinoma, Non-Small Cell Lung Cancer (NA-NSCLC) Patients: a Retrospective Study and Literature Review. Target Oncol. 2018 Oct;13(5):631–9. doi: 10.1007/s11523-018-0592-z. PMID: 30218431.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_eea831d5d36d3a98565f3926f7111b73 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e3330e3c88e8a904fa1b109dc7178a3f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e45870ccb04bb7d330ded8a894817fb3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5ef7ef4143cf2b66733c67c01d779121 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fc31a1de01acfa167cd0f453c296bd97 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_325101bd5fd390549fa483a8847dc3cf http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b0731eea4be18b9d8eae72a589dc751b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c49e070cd01ca53f55128ce34e8bc3fe http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9f8fd13498904003605634cb0fa3501f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4f414fa6845f7d062ddf26dc0d89d635 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_53cd8ce6f27a80af59906b1940075821
date	2018-09-14^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1007/s11523-018-0592-z https://pubmed.ncbi.nlm.nih.gov/30218431
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/35747 https://portal.issn.org/resource/ISSN/1776-260X https://portal.issn.org/resource/ISSN/1776-2596
language	English
source	https://scigraph.springernature.com/ https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Characteristics and Response to Crizotinib in ALK-Rearranged, Advanced Non-Adenocarcinoma, Non-Small Cell Lung Cancer (NA-NSCLC) Patients: a Retrospective Study and Literature Review
discusses	http://id.nlm.nih.gov/mesh/M0228330 http://id.nlm.nih.gov/mesh/M0553416
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D000077548Q000378 http://id.nlm.nih.gov/mesh/D000077547Q000627 http://id.nlm.nih.gov/mesh/D008175Q000188 http://id.nlm.nih.gov/mesh/D002289Q000188
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D002289Q000473 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D000077547Q000494 http://id.nlm.nih.gov/mesh/D012189 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D008175Q000473
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6650 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11431 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7168 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6795 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11626560 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_b23065537a07b03ba7e2ca1197841172

Showing number of triples: 1 to 54 of 54.